The upcoming decade could mark another turning point in the fight against HIV/AIDS, with current research showing potential for a HIV vaccine to be developed by 2021.
Researchers at the Bridge HIV research program in the United States have developed a trio of potential vaccines. While they are still undergoing rigorous trials, scientists are optimistic that the vaccines could pass testing by 2021.
The three vaccines have been developed to target different subtypes of the virus, including one which has ravaged populations in southern Africa.
Dr Susan Buchbinder from the research program has described the success of the trials being “one of the most optimistic moments we have been in”.
“We have three vaccines currently being tested in efficacy trials, and it takes quite a bit to actually be promising enough in the earlier stages of trials to move you forward into an efficacy study,” she said.